Annotation Detail for OR1I1
Basic Information
Top
| Gene Symbol: | OR1I1 ( OR19-20,OR1I1P,OR1I1Q ) |
|---|
| Gene Full Name: | olfactory receptor, family 1, subfamily I, member 1 |
|---|
| Band: | 19p13.1 |
|---|
| Quick Links | Entrez ID:126370; OMIM: NA; Uniprot ID:OR1I1_HUMAN; ENSEMBL ID: ENSG00000094661; HGNC ID: 8207 |
|---|
| Relate to Another Database: |
SFARIGene;
denovo-db |
| Pathway ID | Pathway Name |
|---|
| hsa04740 | Olfactory transduction |
| Pathway ID | Pathway Name |
|---|
| Signaling by GPCR |
| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| D017638 |
Asbestos, Crocidolite |
Asbestos, Crocidolite affects the expression of OR1I1 mRNA | affects expression | 17331233
|
| D004317 |
Doxorubicin |
OR1I1 protein affects the susceptibility to Doxorubicin | affects response to substance | 16217747
|
| D014747 |
Vinblastine |
OR1I1 protein affects the susceptibility to Vinblastine | affects response to substance | 16217747
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
2.65 | 17418594 |
| MESH:D000419 |
Albuminuria |
|
Doxorubicin |
5.13 | 21441931 |
| MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
5.57 | 14601052 |
| MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
4.26 | 17150277 |
| MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
2.57 | 18234424 17369602 16096432 17983394 19526202 15668708 16264153 15994142 18628466 15634643 18695136 16115903 16935488 16322301 18382427 16595493 15939500 15993339 15136595 16826403 17426702 15692762 15567936 11325840 |
| MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
5.68 | 16051944 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
2.26 | 17876044 18059187 16023760 16234567 |
| MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
7.53 | 1485588 16201981 |
| MESH:D002292 |
Carcinoma, Renal Cell |
|
Vinblastine |
7.53 | 1485588 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
2.73 | 6189445 |
| MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.80 | 16952015 17351982 16278810 17308081 15811867 18627295 16612575 16364871 17382496 17329180 15792986 15476868 16269455 16242529 17007740 17131338 17974986 16455267 16109756 16651473 17928571 17519947 17924179 16731534 15505089 |
| MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
3.06 | 16243910 17334414 |
| MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
3.01 | 18802399 18259882 |
| MESH:D015179 |
Colorectal Neoplasms |
|
Vinblastine |
3.01 | 18802399 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
2.53 | 17416283 |
| MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
3.99 | 18602426 |
| MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
3.72 | 17359293 |
| MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
6.02 | 18037988 |
| MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
5.33 | 19069698 |
| MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
3.61 | 17150277 |
| MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
3.81 | 15692506 |
| MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.78 | 18006777 16144979 16244372 16707910 16244371 12587719 16879835 16495754 14766674 17888722 18674790 16330681 17875725 |
| MESH:D006333 |
Heart Failure |
|
Doxorubicin |
3.59 | 17481944 |
| MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
4.38 | 15692506 |
| MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
9.20 | 15147373 18501091 17606976 |
| MESH:D006689 |
Hodgkin Disease |
|
Vinblastine |
9.20 | 18501091 18180244 |
| MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
3.28 | 15699352 15369732 16775033 |
| MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
4.64 | 16707910 |
| MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
6.02 | 16085563 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
2.16 | 16439617 16595196 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
3.26 | 17085340 16842330 |
| MESH:D055370 |
Lung Injury |
|
Asbestos, Crocidolite |
4.67 | 17365036 |
| MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
2.15 | 6189445 17418594 |
| MESH:D008223 |
Lymphoma |
|
Doxorubicin |
3.77 | 16098063 |
| MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
4.18 | 17654614 |
| MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
5.22 | 15621674 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
3.29 | 15458769 |
| MESH:D008545 |
Melanoma |
|
Doxorubicin |
3.97 | 16827129 |
| MESH:D008545 |
Melanoma |
|
Vinblastine |
3.97 | 16432458 16248763 18505091 18332650 16809738 15577323 15577320 17761969 18176117 12374674 |
| MESH:D008654 |
Mesothelioma |
|
Asbestos, Crocidolite |
6.90 | 16966607 18303189 16166281 |
| MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
6.90 | 17638057 |
| MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.98 | 15792986 |
| MESH:D052016 |
Mucositis |
|
Doxorubicin |
5.53 | 17415656 |
| MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
3.09 | 19429709 15857846 |
| MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
3.09 | 18259882 |
| MESH:D009401 |
Nephrosis |
|
Doxorubicin |
5.42 | 16636307 16899518 |
| MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
4.42 | 16889571 15640375 |
| MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
3.45 | 15555623 |
| MESH:D009503 |
Neutropenia |
|
Vinblastine |
5.10 | 17378895 |
| MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
4.48 | 15930896 |
| MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
6.02 | 17983394 |
| MESH:D010995 |
Pleural Diseases |
|
Asbestos, Crocidolite |
5.55 | 10923243 |
| MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
6.02 | 17638057 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
3.49 | 16729912 18437689 15897917 16868541 15749863 16888761 |
| MESH:D011658 |
Pulmonary Fibrosis |
|
Asbestos, Crocidolite |
3.16 | 17365031 15814490 17975199 17322281 |
| MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
4.87 | 17922066 |
| MESH:D012509 |
Sarcoma |
|
Doxorubicin |
4.44 | 17203757 16767912 17710206 15625365 15675481 18313854 |
| MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
4.83 | 14601052 16326096 |
| MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
5.53 | 17846226 |
| MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
3.12 | 15692506 |
| MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
5.22 | 17203757 15625365 16767912 |
| MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
3.71 | 16010429 17909728 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
2.89 | 17653716 |
| MESH:D014625 |
Vaginal Neoplasms |
|
Vinblastine |
5.70 | 15577323 |
| MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
4.87 | 17334414 16364871 17678736 17638931 |
Related Diseases/Disorders